Who has invested in Bluebird Bio?

Anthemis, Axel Springer Digital Ventures are named among the investors backing Bluebird Bio.

Bluebird Bio Funding: $150M Raised, Series C (2020)

Bluebird Bio funding overview

Bluebird Bio is based in Somerville, Massachusetts. Bluebird Bio has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2020. The round record for Bluebird Bio runs through 2020; nothing later has been disclosed. Investors on record include Anthemis, Axel Springer Digital Ventures. 2 distinct backers are named across the disclosed rounds.

Bluebird Bio at a glance

Total raised: $150M
Latest round: Series C
Latest round date: January 2020
Headquarters: Somerville, Massachusetts
Notable investors: Anthemis, Axel Springer Digital Ventures

Frequently asked about Bluebird Bio funding

How much has Bluebird Bio raised?: Bluebird Bio has raised $150M in total disclosed funding across the rounds on record.
Who has invested in Bluebird Bio?: Anthemis, Axel Springer Digital Ventures are named among the investors backing Bluebird Bio.
What was the latest Bluebird Bio funding round?: The most recent disclosed round is a Series C, announced in January 2020.
Where is Bluebird Bio based?: Bluebird Bio is based in Somerville, Massachusetts.
When did Bluebird Bio last raise?: The last disclosed Bluebird Bio round closed in January 2020 at Series C.

Bluebird Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Somerville below to benchmark round size and investor mix.

Bluebird Bio Funding: $150M Raised, Series C (2020)

Bluebird Bio funding overview

Bluebird Bio at a glance

Frequently asked about Bluebird Bio funding

Companies related to Bluebird Bio (14)

Browse related funding lists (4)